|
Risk factors
|
Baseline (N = 467)
|
Follow-up (N = 618)
|
Baseline vs. Follow-up Differencea
|
Interactionb
|
|---|
| | | |
OR (95 % CI)/difference in means
|
P-value
|
P-value
|
|---|
|
Intervention
|
|
Current smoker, % (n/N)
|
5.4 (14/260)
|
7.2 (27/374)
|
2.059 (0.933–4.545)
|
0.074
|
0.829
|
|
Diabetes, % (n/N)
|
15.8 (41/260)
|
19.3 (72/374)
|
1.354 (0.872–2.102)
|
0.177
|
0.973
|
|
Newly diagnosed hypertension, % (n/N)
|
25.4 (66/260)
|
47.1 (176/374)
|
2.520 (1.743–3.643)
|
< 0.001
|
0.184
|
|
History of CVD, % (n/N)
|
20.0 (52/260)
|
13.1 (49/374)
|
0.653 (0.397–1.074)
|
0.093
|
0.537
|
|
SBP, mean ± SD
|
146.52 ± 14.25
|
137.80 ± 12.07
|
-8.51 (-10.65–6.37)
|
< 0.001
|
< 0.001
|
|
DBP, mean ± SD
|
91.80 ± 9.04
|
86.61 ± 7.85
|
-5.30 (-6.65–3.96)
|
< 0.001
|
< 0.001
|
|
Control
|
|
Current smoker, % (n/N)
|
6.8 (14/207)
|
9.0 (22/244)
|
1.869 (0.759–4.598)
|
0.173
| |
|
Diabetes, % (n/N)
|
18.8 (39/207)
|
23.4 (57/244)
|
1.371 (0.843–2.231)
|
0.204
| |
|
Newly diagnosed hypertension, % (n/N)
|
14.0 (29/207)
|
19.7 (48/244)
|
1.565 (0.931–2.631)
|
0.091
| |
|
History of CVD, % (n/N)
|
41.5 (86/207)
|
37.7 (92/244)
|
0.767 (0.509–1.156)
|
0.205
| |
|
SBP, mean ± SD
|
142.28 ± 16.58
|
141.49 ± 14.21
|
-0.52 (-3.36-2.32)
|
0.721
| |
|
DBP, mean ± SD
|
89.83 ± 8.89
|
89.85 ± 9.29
|
0.07 (-1.63-1.77)
|
0.932
| |
- CVD cardiovascular disease; SBP systolic blood pressure; DBP diastolic blood pressure; SD standard deviation; OR odds ratio; CI confidence interval
- a Adjusted for age, gender, and clinic.
- b Interaction for intervention and control clinics adjusted for age, gender, and clinic.
